- Abstract
Background
Major depressive disorder (MDD) is the leading cause of disability worldwide. Response to pharmacologic treatment is generally evaluated by traditional clinician- and patient-reported rating scales.
Maggie McCue et al., BMC Psychiatry. 2021; 21: 622.
Published online 2021 Dec 11. doi: 10.1186/s12888-021-03608-1